RecruitingPhase 2NCT06344260
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Casa Sollievo della Sofferenza IRCCS
- Principal Investigator
- Angelo L Vescovi, PhDScientific Director Fondazione IRCCS "Casa Sollievo della Sofferenza"
- Intervention
- human Neural Stem Cells (hNSC)(procedure)
- Enrollment
- 30 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2024 – 2027
Study locations (4)
- Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo, Foggia, Italy
- Centro SLA Azienda Ospedaliera Università Maggiore della Carità, Novara, Italy
- Azienda Ospedaliera di Padova, Padua, Italy
- Azienza Ospedaliera Universitaria - Policlinico "P. Giaccone" Università degli Studi di Palermo, Palermo, Italy
Collaborators
Ministry of Health, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06344260 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia